Abdominal paresthesia resembling restless legs syndrome successfully treated with iron supplement therapy: A case report

2014 ◽  
Vol 336 (1-2) ◽  
pp. 291-292 ◽  
Author(s):  
Masahiro Suzuki ◽  
Koju Yamada ◽  
Tadashi Kanamori ◽  
Chisato Konno ◽  
Michiko Konno ◽  
...  
Author(s):  
Taylor Fields ◽  
Benedikt Schoser ◽  
Wolfgang Oertel ◽  
Michael Strupp

Author(s):  
Guo-Mei Shi ◽  
Xiao-Rong Wang ◽  
Wu Xu ◽  
Min-Wang Guo ◽  
Chun-Qin Ding ◽  
...  

2021 ◽  
pp. 578-583
Author(s):  
Katherine Condon ◽  
James Chipman

Restless legs syndrome (RLS) is a debilitating neurological disorder for which a range of medical interventions with varied efficacy has been employed. Based on evidence of iron deficiency in the substantia nigra of the midbrain, there are reports of substantial benefits from intravenous iron infusion. This case report demonstrates a strong statistically significant negative correlation between serum ferritin and RLS severity of symptoms in a subject with RLS who received 2 intravenous infusions of ferric carboxymaltose over a period of 464 days. The results provide further evidence to support the treatment strategy.


2011 ◽  
Vol 6 (2) ◽  
pp. 344-349
Author(s):  
Hideaki Hasuo ◽  
Tatsuhiko Ishihara ◽  
Naoko Hata ◽  
Mika Saigusa ◽  
Midori Okada ◽  
...  

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Itaru Nakamura ◽  
Takao Itoi ◽  
Takeshi Inoue

Abstract Background Coronavirus disease 2019 (COVID-19) has a broad spectrum from respiratory and nasopharyngeal symptoms, cerebrovascular diseases, impaired consciousness, and skeletal muscle injury. Emerging evidence has indicated the neural spread of this novel coronavirus. Restless legs syndrome (RLS) is a common neurological, sensorimotor disorder, but highly under diagnosis disorder. Restless anal syndrome as restless legs syndrome variant associated with COVID-19 has been previously not published. We report a case presenting with restless anal syndrome following COVID-19. Case presentation Although a 77-year-old male with COVID-19 improved to normal respiratory function 21 days after admission and treatment of favipiravir 200 mg per day for 14 days and dexamethasone 6.6 mg per day for 5 days, the insomnia and anxiety symptoms remained. Several weeks after discharge, he gradually began to experience restless, deep anal discomfort, approximately 10 cm from the perineal region. The following features were observed in the anal region; urge to move is essential, with worsening with rest, improvement with exercise, and worsening at evening. Colonoscopy revealed internal haemorrhoids without other rectal lesions. Neurological findings including deep tendon reflex, perineum loss of sensory and spinal cord injury, revealed no abnormalities. Diabetes militias, kidney dysfunction and iron deficiency status were not confirmed. Family history of RLS and periodic limb movements were not observed. Clonazepam at 1.5 mg per day resulted in the alleviation restless anal discomfort. Conclusions We reported a case presenting with restless anal syndrome following affection of COVID-19 as restless legs syndrome variant. This case fulfilled 4 essential features of RLS, urge to move, worsening with rest, improvement with exercise, and worsening at evening. To date, no case of restless anal syndrome associated with COVID-19 has been previously published. This case report may reflect the associative impacts of COVID-19 on the neuropsychiatric state. The long-term outcomes of neuropsychiatric conditions should continue to be monitored.


Sign in / Sign up

Export Citation Format

Share Document